• Exchange: SIX Swiss Ex
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Orthopedic Devices

Nobel Biocare Holding AG

+ Add to Watchlist


12.050 CHF 0.150 1.26%

As of 11:43:41 ET on 04/17/2014.

Snapshot for Nobel Biocare Holding AG (NOBN)

Open: 11.950 Day's Range: 11.900 - 12.150 Volume: 344,412
Previous Close: 11.900 52wk Range: 8.661 - 15.305 1-Yr Rtn: +36.75%

Stock Chart for NOBN

No chart data available.
  • NOBN:SW 12.050
  • 1D
  • 1M
  • 1Y
Interactive NOBN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NOBN

Current P/E Ratio (ttm) 28.2304
Estimated P/E(12/2014) 23.5804
Relative P/E vs. SMI 1.4663
Earnings Per Share (EUR) (ttm) 0.3500
Est. EPS (EUR) (12/2014) 0.4190
Est. PEG Ratio 1.3228
Market Cap (M CHF) 1,491.60
Shares Outstanding (M) 123.78
30 Day Average Volume 395,718
Price/Book (mrq) 3.6154
Price/Sale (ttm) 2.1407
Dividend Indicated Gross Yield 1.66%
Cash Dividend (CHF) 0.2000
Dividend Ex-Date 03/28/2014
5 Year Dividend Growth -18.32%
Next Earnings Announcement 04/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NOBN

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for NOBN

Nobel Biocare Holding AG develops and produces dental implants and dental prosthetics. The Company manufactures permanent replacements for tooth roots, and dental crowns and bridges. Nobel Biocare sells under the brand names Branemark System, Steri-Oss/Replace, and Procera on the global market.

Richard T LaubeChief Executive OfficerOliver WalkerChief Financial Officer
Hans GeiselhoringerExec VP:Global ResearchMelker NilssonExec VP:Global Customer
More Company Profile & Key Executives for NOBN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil